Vol. 24 No. 3S (2020): Frontiers of endovascular surgery
CASE REPORTS

Hybrid minimally invasive multivessel coronary artery bypass grafting to achieve complete myocardial revascularisation: the first clinical case

PDF (Русский)
  • I. Shabaev,
  • K. Kozyrin,
  • R. Tarasov
I. Shabaev
Research Institute For Complex Problems Of Cardiovascular Diseases, Kemerovo
Bio
K. Kozyrin
Research Institute For Complex Problems Of Cardiovascular Diseases, Kemerovo
R. Tarasov
Research Institute For Complex Problems Of Cardiovascular Diseases, Kemerovo
DOI: https://doi.org/10.21688/1681-3472-2020-3S-108-118

Published 2020-11-06

Keywords

  • clinical case,
  • hybrid revascularisation,
  • MICS-CABG,
  • minimally invasive coronary artery bypass grafting,
  • off-pump coronary artery bypass grafting

How to Cite

Shabaev, I., Kozyrin, K., & Tarasov, R. (2020). Hybrid minimally invasive multivessel coronary artery bypass grafting to achieve complete myocardial revascularisation: the first clinical case. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 24(3S), 108–118. https://doi.org/10.21688/1681-3472-2020-3S-108-118

Copyright (c) 2020 Shabaev I.F., Kozyrin K.A., Tarasov R.S.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Aim. To report the first clinical case of the hybrid procedure combining off-pump minimally invasive multivessel coronary artery bypass grafting (MICS-CABG) and percutaneous coronary intervention (PCI) of the obtuse marginal (OM) artery to achieve complete myocardial revascularisation.
Clinical case. Bilateral in situ skeletonised left internal mammary artery (IMA) grafting to the left anterior descending artery was performed, and a Y-shape anastomosis was created from the left IMA-right IMA to the circumflex branch. At 2 hours postoperatively, graft failure caused by subtotal stenosis at the graft was diagnosed. Reconstruction of the anastomosis improved the transit time flow measurement by 3.5 hours postoperatively. Acute myocardial infarction did not develop. On postoperative day 1, graft patency was assessed, and then the OM stent was placed. On postoperative day 8, the patient was discharged and referred to the outpatient centre for further treatment and rehabilitation. Hybrid revascularisation offers the advantages of both CABG and PCI; however, the technical complexity is a major limitation for its widespread use. This case reports the development of adverse events during the surgeon's training to perform this nonstandard technology. Timely diagnosis of the initial graft failure and surgical revision led to a successful and complication-free outcome and avoided prolonged patient rehabilitation.
Conclusion. Hybrid revascularisation combining MICS-CABG and PCI with new-generation drug-eluting stents can be a worthwhile alternative to conventional multivessel CABG with minimal invasiveness and complete revascularisation.

Received 5 June 2020. Revised 10 September 2020. Accepted 15 September 2020.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

PDF (Русский)

References

  1. Authors/Task Force members, Windecker S., Kolh P., Alfonso F., Collet J.-P., Cremer J., Falk V., Filippatos G., Hamm C., Head S.J., Jüni P., Kappetein A.P., Kastrati A., Knuuti J., Landmesser U., Laufer G., Neumann F.-J., Richter D.J., Schauerte P., Uva M.S., Stefanini G.G., Taggart D.P., Torracca L., Valgimigli M., Wijns W., Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. PMID: 25173339. https://doi.org/10.1093/eurheartj/ehu278
  2. Makikallio T., Holm N.R., Lindsay M., Spence M.S., Erglis A., Menown I.B.A., Trovik T., Eskola M., Romppanen H., Kellerth T., Ravkilde J., Jensen L.O., Kalinauskas G., Linder R.B.A., Pentikainen M., Hervold A., Banning A., Zaman A., Cotton J., Eriksen E., Margus S., Sørensen H.T., Nielsen P.H., Niemelä M., Kervinen K., Lassen J.F., Maeng M., Oldroyd K., Berg G., Walsh S.J., Hanratty C.G., Kumsars I., Stradins P., Steigen T.K., Fröbert O., Graham A.N.J., Endresen P.C., Corbascio M., Kajander O., Trivedi U., Hartikainen J., Anttila V., Hildick-Smith D., Thuesen L., Christiansen E.H., NOBLE study investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743-2752. PMID: 27810312. https://doi.org/10.1016/S0140-6736(16)32052-9
  3. Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., Généreux P., Puskas J., Kandzari D.E., Morice M.-C., Lembo N., Brown W.M. 3rd, Taggart D.P., Banning A., Merkely B., Horkay F., Boonstra P.W., van Boven A.J., Ungi I., Bogáts G., Mansour S., Noiseux N., Sabaté M., Pomar J., Hickey M., Gershlick A., Buszman P., Bochenek A., Schampaert E., Pagé P., Dressler O., Kosmidou I., Mehran R., Pocock S.J., Kappetein A.P., EXCEL Trial Investigators. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223-2235. PMID: 27797291. https://doi.org/10.1056/NEJMoa1610227
  4. Buszman P.E., Buszman P.P., Banasiewicz-Szkróbka I., Milewski K.P., Żurakowski A., Orlik B., Konkolewska M., Trela B., Janas A., Martin J.L., Kiesz R.S., Bochenek A. Left Main stenting in comparison with surgical revascularization: 10-year outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial. JACC Cardiovasc Interv. 2016;9(4):318-327. PMID: 26892080. https://doi.org/10.1016/j.jcin.2015.10.044
  5. Ahn J.-M., Roh J.-H., Kim Y.-H., Park D.-W., Yun S.-C., Lee P.H., Chang M., Park H.W., Lee S.-W., Lee C.W., Park S.-W., Choo S.J., Chung C.H., Lee J.W., Lim D.-S., Rha S.-W., Lee S.-G., Gwon H.-C., Kim H.-S., Chae I.-H., Jang Y., Jeong M.-H., Tahk S.-J., Seung K.B., Park S.-J. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT Study. J Am Coll Cardiol. 2015;65(20):2198-2206. PMID: 25787197. https://doi.org/10.1016/j.jacc.2015.03.033
  6. Morice M.-C., Serruys P.W., Kappetein A.P., Feldman T.E., Ståhle E., Colombo A., Mack M.J., Holmes D.R., Choi J.W., Ruzyllo W., Religa G., Huang J., Roy K., Dawkins K.D., Mohr F. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery trial. Circulation. 2014;129(23):2388-2394. PMID: 24700706. https://doi.org/10.1161/CIRCULATIONAHA.113.006689
  7. Putzu A., Gallo M., Martino E.A., Ferrari E., Pedrazzini G., Moccetti T., Cassina T. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials. Int J Cardiol. 2017;241:142-148. PMID: 28438354. https://doi.org/10.1016/j.ijcard.2017.04.015
  8. De Rosa S., Polimeni A., Sabatino J., Indolfi C. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: A meta-analysis. BMC Cardiovasc Disord. 2017;17(1):240. PMID: 28877676, PMCID: PMC5588710. https://doi.org/10.1186/s12872-017-0664-5
  9. Garg A., Rao S.V., Agrawal S., Theodoropoulos K., Mennuni M., Sharma A., Garg L., Ferrante G., Meelu O.A., Sargsyan D., Reimers B., Cohen M., Kostis J.B., Stefanini G.G. Meta-Analysis of randomized controlled trials of percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease. Am J Cardiol. 2017;119(12):1942-1948. PMID: 28433215. https://doi.org/10.1016/j.amjcard.2017.03.019
  10. Lee C.W., Ahn J.-M., Cavalcante R., Sotomi Y., Onuma Y., Suwannasom P., Tenekecioglu E., Yun S.-C., Park D.-W., Kang S.-J., Lee S.-W., Kim Y.-H., Park S.-W., Serruys P.W., Park S.-J. Coronary artery bypass surgery versus drug-eluting stent implantation for left main or multivessel coronary artery disease: A meta-analysis of individual patient data. JACC Cardiovasc Interv. 2016;9(24):2481-2489. PMID: 28007199. https://doi.org/10.1016/j.jcin.2016.10.008
  11. Nerlekar N., Ha F.J., Verma K.P., Bennett M.R., Cameron J.D., Meredith I.T., Brown A.J. Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery stenosis: A meta-analysis of randomized trials. Circ Cardiovasc Interv. 2016;9(12):e004729. PMID: 27899408. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004729
  12. McGinn J.T. Jr, Usman S., Lapierre H., Pothula V.R., Mesana T.G., Ruel M. Minimally invasive coronary artery bypass grafting: dual-center experience in 450 consecutive patients. Circulation. 2009;120(11 Suppl):S78-S84. PMID: 19752390. https://doi.org/10.1161/CIRCULATIONAHA.108.840041
  13. Hoff S.J., Ball S.K., Leacche M., Solenkova N., Umakanthan R., Petracek M.R., Ahmad R., Greelish J.P., Walker K., Byrne J.G. Results of completion arteriography after minimally invasive off-pump coronary artery bypass. Ann Thorac Surg. 2011;91(1):31-36. PMID: 21172481. https://doi.org/10.1016/j.athoracsur.2010.09.057
  14. Chan V., Lapierre H., Sohmer B., Mesana T.G., Ruel M. Handsewn proximal anastomoses onto the ascending aorta through a small left thoracotomy during minimally invasive multivessel coronary artery bypass grafting: a stepwise approach to safety and reproducibility. Semin Thorac Cardiovasc Surg. 2012;24(1):79-83. PMID: 22643668. https://doi.org/10.1053/j.semtcvs.2011.12.010
  15. Mack M., Acuff T., Yong P., Jett G.K., Carter D. Minimally invasive thoracoscopically assisted coronary artery bypass surgery. Eur J Cardiothorac Surg. 1997;12(1):20-24. PMID: 9262076. https://doi.org/10.1016/s1010-7940(97)00141-3
  16. Raja S.G. Total arterial coronary grafting: outcomes, concerns and controversies. Vessel Plus. 2019;(3):23. http://dx.doi.org/10.20517/2574-1209.2019.05
  17. D'Ancona G., Vassiliades T.A., Boyd W.D., Donias H.W., Stahl K.D., Karamanoukian H. Is hybrid coronary revascularization favored by cardiologists or cardiac surgeons? Heart Surg Forum. 2002;5(4):393-395. PMID: 12538124
  18. Жбанов И.В., Киладзе И.З., Урюжников В.В., Шабалкин Б.В. Миниинвазивная коронарная хирургия. Кардиология и сердечно-сосудистая хирургия. 2019;12(5):377-385. [Zhbanov I.V., Kiladze I.Z., Uryuzhnikov V.V., Shabalkin B.V. Minimally invasive coronary artery bypass surgery. Russian Journal of Cardiology and Cardiovascular Surgery = Kardiologiya i serdechno-sosudistaya khirurgiya. 2019;12(5):377-385. (In Russ.)] http://dx.doi.org/10.17116/kardio201912051377
  19. Зеньков А.А., Островский Ю.П., Выхристенко К.С., Лойко Н.Г. Сравнительный анализ результатов миниинвазивной реваскуляризации миокарда, коронарного шунтирования на работающем сердце и с искусственным кровообращением. Новости хирургии. 2014;22(1):33-43. [Ziankou A.A., Ostrovskij U.P., Vuhristenko K.S., Lojko N.G. Comparative analysis of the results of minimally invasive myocardial revascularization and coronary artery bypass grafting on the beating heart and with artificial blood circulation. Novosti Khirurgii. 2014;22(1):33-43. (In Russ.)] http://dx.doi.org/10.18484/2305-0047.2014.1.33
  20. Holzhey D.M., Jacobs S., Walther T., Mochalski M., Mohr F.W., Falk V. Cumulative sum failure analysis for eight surgeons performing minimally invasive direct coronary artery bypass. J Thorac Cardiovasc Surg. 2007;134(3):663-669. PMID: 17723815. https://doi.org/10.1016/j.jtcvs.2007.03.029
  21. Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D., Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. PMID: 30153967. https://doi.org/10.1016/j.jacc.2018.08.1038
  22. Шилов А.А., Кочергин Н.А., Ганюков В.И., Козырин К.А., Барбараш Л.С. Гибридная стратегия реваскуляризации миокарда в сравнении с аортокоронарным шунтированием у пациентов с многососудистым поражением коронарного русла при стабильной ишемической болезни сердца, тридцатидневные результаты. Комплексные проблемы сердечно-сосудистых заболеваний. 2016;5(3):16-20. [Shilov A.A., Kochergin N.A., Ganyukov V.I., Kozyrin K.A., Barbarash L.S. Hybrid strategy of revascularization compared with coronary artery bypass grafting in patients with multivessel coronary disease with stable coronary artery disease, thirty results. Complex Issues of Cardiovascular Diseases. 2016;5(3):16-20. (In Russ.)] https://doi.org/10.17802/2306-1278-2016-3-16-20